ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,427.13
-2.31%
Dow Jones
39,853.87
0.00%
US Dollar vs MXN
18.5107
0.80%
Brent Oil
79.545
-1.47%
Bitcoin
64,184.38
-1.82%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
25/07/202407:30GlobeNewswire Inc.Turtle Beach Corporation Appoints Libby Bush to Board of DirectorsNASDAQ:HEARTurtle Beach Corporation
25/07/202407:30GlobeNewswire Inc.Kearny Financial Corp. Announces Fourth Quarter and Fiscal Year End 2024 Results and Declaration of $0.11 Per Share Cash DividendNASDAQ:KRNYKearny Financial Corporation
25/07/202407:30Business WireCrescent Energy and SilverBow Resources Announce Preliminary Results for Election of Form of Merger ConsiderationNYSE:CRGYCrescent Energy Company
25/07/202407:30GlobeNewswire Inc.GCM Grosvenor to Announce Second Quarter 2024 Financial Results and Host Investor Conference Call on August 8, 2024NASDAQ:GCMGGCM Grosvenor Inc
25/07/202407:30Business WireAditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the AcquisitionTSX:APLIAppili Therapeutics Inc
25/07/202407:30Business WireMirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and OlderNASDAQ:MIRMMirum Pharmaceuticals Inc
25/07/202407:30GlobeNewswire Inc.IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1stNASDAQ:IRMDiRadimed Corporation
25/07/202407:30GlobeNewswire Inc.HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform HealthcareNASDAQ:HSCSWHeart Test Laboratories Inc
25/07/202407:30Business WireStem Announces Second Quarter 2024 Earnings Results Conference CallNYSE:STEMStem Inc
25/07/202407:30Business Wireコーペイ・クロスボーダー、ワールドアスレティックスの外国為替に関する公式サプライヤーに任命NYSE:CPAYCorpay Inc
25/07/202407:30GlobeNewswire Inc.Heliene and Premier Energies, India – Announce Joint Venture to Build a U.S.-Based Solar Cell Manufacturing Facility
25/07/202407:30Business WireNETGEAR Announces New Additions to its Board of Directors and Management Team to Fuel Growth Across Company SectorsNASDAQ:NTGRNETGEAR Inc
25/07/202407:30Business WireXPEL, Inc. to Host Conference Call to Discuss Second Quarter 2024 ResultsNASDAQ:XPELXPEL Inc
25/07/202407:30GlobeNewswire Inc.Safe Harbor Financial and BIPOCann Team Up to Empower Minority-Owned Cannabis BusinessesNASDAQ:SHFSSHF Holdings Inc
25/07/202407:30Business WireCorpay Cross-Border wird offizieller weltweiter Devisenzahlungsanbieter von World AthleticsNYSE:CPAYCorpay Inc
25/07/202407:30Business WireLuxury Home Prices Spike 9% to All-Time HighNASDAQ:RDFNRedfin Corporation
25/07/202407:30Business WireACORE Capital Appoints Matt Drummond as Head of High-Yield Strategies
25/07/202407:30GlobeNewswire Inc.Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel FunctionNASDAQ:INZYInozyme Pharma Inc
25/07/202407:30Business WireCorpay Cross-Border Named the Official World Athletics Foreign Exchange SupplierNYSE:CPAYCorpay Inc
25/07/202407:30Business WireAmprius Technologies Announces Date for Second Quarter 2024 Results and Business UpdatesNYSE:AMPXAmprius Technologies Inc
25/07/202407:30GlobeNewswire Inc.Supremex Announces Date of Its 2024 Second Quarter Results Conference CallTSX:SXPSupremex Inc
25/07/202407:30Business WireAmerican Eagle Wants to Inspire You to ‘Live Your Life’ Through Self-Expression and ConnectionNYSE:AEOAmerican Eagle Outfitters Inc
25/07/202407:30Business WireCorpay Cross-Border nommé fournisseur officiel en devises étrangères de World AthleticsNYSE:CPAYCorpay Inc
25/07/202407:30GlobeNewswire Inc.GEN Restaurant Group, Inc. Appoints David Park to its Board of DirectorsNASDAQ:GENKGEN Restaurant Group Inc
25/07/202407:30GlobeNewswire Inc.West Bancorporation, Inc. Announces Second Quarter 2024 Financial Results and Declares Quarterly DividendNASDAQ:WTBAWest Bancorporation
25/07/202407:30GlobeNewswire Inc.Great Pacific Gold Appoints Greg McCunn as CEO and DirectorTG:V3HGreat Pacific Gold Corp
25/07/202407:30GlobeNewswire Inc.Catalyst Funds and Welton Investment Partners Launch the Catalyst/Welton Advantage Multi-Strategy FundNASDAQ:CWEAXCatalystwelton Advantage Multistrategy Fund Class A
25/07/202407:30GlobeNewswire Inc.Temenos strengthens commitment to SaaS and the US with key executive appointments
25/07/202407:30Business WireBobbie Joins Forces with New Dad Tan France To Continue Advocating For Paid Leave Amid Alarming Statistics: 70% of New Fathers in the U.S. Return to Work Within Two Weeks
25/07/202407:30GlobeNewswire Inc.AMMO, Inc. to Conduct Fiscal First Quarter 2025 Earnings Call on August 8, 2024, at 5:00PM ETNASDAQ:POWWAMMO Inc

Su Consulta Reciente

NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
NASDAQ
TSLA
Tesla
FX
EURMXN
Euro vs MXN
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
CCOM
OILBRENT
Brent Oil
COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados